CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE? | Zendy

Gabriel Rubio | Zendy; G. Ponce | Zendy; Roberto RodríguezJiménez | Zendy; Miguel Ángel JiménezArriero | Zendy; Janet Hoenicka | Zendy; Tomás Palomo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?

Author(s) -

Gabriel Rubio,

G. Ponce,

Roberto RodríguezJiménez,

Miguel Ángel JiménezArriero,

Janet Hoenicka,

Tomás Palomo

Publication year - 2005

Publication title -

alcohol and alcoholism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.747

H-Index - 99

eISSN - 1464-3502

pISSN - 0735-0414

DOI - 10.1093/alcalc/agh151

Subject(s) - naltrexone , abstinence , alcohol dependence , medicine , detoxification (alternative medicine) , randomized controlled trial , psychiatry , narcotic antagonist , psychology , alcohol , antagonist , biochemistry , chemistry , receptor , alternative medicine , pathology

To determine the clinically ascertained variables that are related to satisfactory response to naltrexone (NTX) treatment of alcohol dependence after detoxification.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research